SK Bio-Pharmaceuticals and Hanmi Pharmaceutical, Co., Ltd Will Bring Epilepsy Treatment to China

April 25, 2012 -- Two Korean biopharmas, SK Biopharmaceuticals and Hanmi Pharm, announced a strategic partnership to bring an epilepsy drug to China and Korea. SK Biopharm developed the drug – the seizure control and muscle relaxant treatment diazepam, which is delivered by a nasal spray. Hanmi’s China subsidiary will be in charge of obtaining SFDA approval for the drug and marketing it in China and Korea. More details....